NEW YORK — Del Laboratories managed to increase second-quarter profits despite charges associated with shifts in its manufacturing.

For the three months ended June 30, net income grew 7.6 percent to $4.9 million, or 52 cents a diluted share, from $4.6 million, or 48 cents, in the year-ago period. Excluding a $1.2 million after-tax charge to cover severance for those affected by the shift of manufacturing to Rocky Point, N.C., from Farmingdale, N.Y., income would have risen 32.8 percent to $6.1 million. Net sales picked up 5.1 percent to $98 million from $93.3 million.

To Read the Full Article
SUBSCRIBE NOW

Tap into our Global Network

Of Industry Leaders and Designers

load comments
blog comments powered by Disqus